Rise in Adoption of Several Strategies Along With the Increasing Geriatric Population Will Accelerate the Growth of the Global Injectable Drug Delivery Market

The global injectable drug delivery market is anticipated to grow at a significant CAGR of 12.8% during the forecast period (2022-2028). Some of the top-selling drugs are delivered using injections and implants. Drugs delivered using injections are considered to act more effectively and for a longer duration compared to orally administered drugs. The major factor driving the growth of the global injectable drug delivery market during the forecast period is due to increasing geriatric population across the globe. According to the Department of Economic and Social Affairs, there were 703 million people aged 65 years or over globally in 2019 which is anticipated to double to 1.5 billion in 2050. Additionally, the growing adoption of modern, technologically advanced solutions is driving the growth of the global injectable drug delivery market. Additionally, the growth of self-injections is very high. The market is overtaking the conventional drug delivery market. It is also driving the market to grow.

Browse the full report description of “Global Injectable Drug Delivery Market Size, Share & Trends Analysis Report by Mode of Administration (Oral and Pulmonary), by Usability (Reusable and Disposable), and by End-User (Hospitals & Clinics, Home Care Settings, and Other) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/injectable-drug-delivery-market  

The major companies serving the global injectable drug delivery market include Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and Pfizer Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and geographical expansion, to stay competitive in the market. For instance, in October 2019, Becton, Dickinson, and Company announced to launch of the BD Intevia 1mL two-step disposable autoinjector. It is a robust platform device combining autoinjector and pre-fillable syringe in one integrated system.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Mode of Administration
• By Usability
• By End-User

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and Pfizer Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

oDeviation from the pre-COVID-19 forecast

oMost affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Injectable Drug Delivery Market Report by Segment

By Mode of Administration

• Oral 
• Pulmonary 

By Usability

• Reusable
• Disposable

By End-User 

• Hospitals & Clinics
• Home Care Settings
• Others

Global Injectable Drug Delivery Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/industry-reports/injectable-drug-delivery-market